Upregulation of HIF‑1α protects neuroblastoma cells from hypoxia‑induced apoptosis in a RhoA‑dependent manner

Yin,Cui‑Ping; Guan,Shang‑Hui; Zhang,Bo; Wang,Xue‑Xin; Yue,Shou‑Wei

doi:10.3892/mmr.2015.4267

Upregulation of HIF‑1α protects neuroblastoma cells from hypoxia‑induced apoptosis in a RhoA‑dependent manner

Authors:
- Cui‑Ping Yin
- Shang‑Hui Guan
- Bo Zhang
- Xue‑Xin Wang
- Shou‑Wei Yue
View Affiliations

Affiliations: Department of Physical Medicine and Rehabilitation, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Physical Medicine and Rehabilitation, Dongying People's Hospital, Dongying, Shandong 257091, P.R. China, Department of Physical Medicine and Rehabilitation, Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China
Published online on: August 28, 2015 https://doi.org/10.3892/mmr.2015.4267
Pages: 7123-7131

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxic conditions regulate several metabolic enzymes and transcription factors that are involved in cancer, ischemia and pulmonary diseases. The Ras homolog (Rho) family, including Rho member A (RhoA), is involved in reorganization of the actin cytoskeleton, cell migration and in the regulation of apoptosis and gene transcription. The aim of the present study was to investigate the expression of hypoxia‑inducible factor (HIF)‑α and the activity of RhoA in PC12 neuroblastoma cells under hypoxic conditions. The upregulation of HIF‑α and RhoA by hypoxia was determined using reverse transcription‑quantitative polymerase chain reaction and western blot assays, cell apoptosis was analyzed using flow cytometry, and the activity of caspase 3 was examined using a western blot assay and caspase 3 activity assay kit. The PC12 cells were induced to apoptosis following exposure to hypoxia, and exhibited increased expression of HIF‑α and increased mRNA and protein expression levels of RhoA. The overexpression of HIF‑α attenuated the hypoxia‑induced apoptosis of the PC12 cells. In addition, RhoA knockdown using small interfering RNA abrogated the antagonism of HIF‑1α towards hypoxia‑induced apoptosis. The results of the present study confirmed the protective role of HIF‑1α and RhoA in hypoxia‑induced PC12 cell apoptosis, and that the upregulation of HIF‑1α by hypoxia is RhoA‑dependent.

View Figures

View References

1	Wishart TM, Parson SH and Gillingwater TH: Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol. 65:733–739. 2006. View Article : Google Scholar : PubMed/NCBI
2	Whiteley W, Tseng MC and Sandercock P: Blood biomarkers in the diagnosis of ischemic stroke: A systematic review. Stroke. 39:2902–2909. 2008. View Article : Google Scholar : PubMed/NCBI
3	Kam PC, Kavanagh R and Yoong FF: The arterial tourniquet: Pathophysiological consequences and anaesthetic implications. Anaesthesia. 56:534–545. 2001. View Article : Google Scholar : PubMed/NCBI
4	McEwen JA: Complications of and improvements in pneumatic tourniquets used in surgery. Med Instrum. 15:253–257. 1981.PubMed/NCBI
5	Rorabeck CH: Tourniquet-induced nerve ischemia: An experimental investigation. J Trauma. 20:280–286. 1980. View Article : Google Scholar : PubMed/NCBI
6	Bickler PE and Donohoe PH: Adaptive responses of vertebrate neurons to hypoxia. J Exp Biol. 205:3579–3586. 2002.PubMed/NCBI
7	Nishimura M: Factors influencing an increase in spontaneous transmitter release by hypoxia at the mouse neuromuscular junction. J Physiol. 372:303–313. 1986. View Article : Google Scholar : PubMed/NCBI
8	Bukharaeva EA, Salakhutdinov RI, Vyskocil F and Nikolsky EE: Spontaneous quantal and non-quantal release of acetylcholine at mouse endplate during onset of hypoxia. Physiol Res. 54:251–255. 2005.PubMed/NCBI
9	David G, Nguyen K and Barrett EF: Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp Neurol. 204:411–420. 2007. View Article : Google Scholar : PubMed/NCBI
10	Hatzipantelis KP, Natsis K and Albani M: Effect of acute limb ischaemia on neuromuscular function in rats. Eur J Surg. 167:831–838. 2001. View Article : Google Scholar
11	Northington FJ, Ferriero DM, Flock DL and Martin LJ: Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci. 21:1931–1938. 2001.PubMed/NCBI
12	Graham SH and Chen J: Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab. 21:99–109. 2001. View Article : Google Scholar : PubMed/NCBI
13	Linnik MD, Zobrist RH and Hatfield MD: Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:2002–2008; discussion 2008–2009. 1993. View Article : Google Scholar : PubMed/NCBI
14	Ferrer I and Planas AM: Signaling of cell death and cell survival following focal cerebral ischemia: Life and death struggle in the penumbra. J Neuropathol Exp Neurol. 62:329–339. 2003.PubMed/NCBI
15	Kato H and Kogure K: Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol. 19:93–108. 1999. View Article : Google Scholar : PubMed/NCBI
16	Newcomb JD, Ajmo CJ, Sanberg CD, Sanberg PR, Pennypacker KR and Willing AE: Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15:213–223. 2006. View Article : Google Scholar : PubMed/NCBI
17	Cummins EP and Taylor CT: Hypoxia-responsive transcription factors. Pflugers Arch. 450:363–371. 2005. View Article : Google Scholar : PubMed/NCBI
18	Licausi F, Weits DA, Pant BD, Scheible WR, Geigenberger P and van Dongen JT: Hypoxia responsive gene expression is mediated by various subsets of transcription factors and miRNAs that are determined by the actual oxygen availability. New Phytol. 190:442–456. 2011. View Article : Google Scholar
19	Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
20	Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
21	Pouyssegur J, Dayan F and Mazure NM: Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kaelin WJ and Ratcliffe PJ: Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell. 30:393–402. 2008. View Article : Google Scholar : PubMed/NCBI
23	Piret JP, Mottet D, Raes M and Michiels C: Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol. 64:889–892. 2002. View Article : Google Scholar : PubMed/NCBI
24	Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J, Niizeki H, Kawamura KI, Hosokawa M and Asaka M: Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.PubMed/NCBI
25	Zhang B, Yin CP, Zhao Q and Yue SW: Upregulation of hif-1α by hypoxia protect neuroblastoma cells from apoptosis by promoting survivin expression. Asian Pac J Cancer Prev. 15:8251–8257. 2014. View Article : Google Scholar
26	Chen D, Li M, Luo J and Gu W: Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 278:13595–13598. 2003. View Article : Google Scholar : PubMed/NCBI
27	Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744. 2003. View Article : Google Scholar : PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
29	Bailly K, Ridley AJ, Hall SM and Haworth SG: RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific. Circ Res. 94:1383–1391. 2004. View Article : Google Scholar : PubMed/NCBI
30	Nicholson DW and Thornberry NA: Apoptosis. Life and death decisions. Science. 299:214–215. 2003. View Article : Google Scholar : PubMed/NCBI
31	Dada LA, Novoa E, Lecuona E, Sun H and Sznajder JI: Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na, K-ATPase in A549 cells. J Cell Sci. 120:2214–2222. 2007. View Article : Google Scholar : PubMed/NCBI
32	Desbuards N, Antier D, Rochefort GY, Apfeldorfer CS, Schenck E, Hanton G and Hyvelin JM: Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: Consequences on pulmonary hypertension. Eur J Pharmacol. 602:355–363. 2009. View Article : Google Scholar
33	Semenza GL: HIF-1 and human disease: One highly involved factor. Genes Dev. 14:1983–1991. 2000.PubMed/NCBI
34	Wang GL and Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
35	Li C and Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 282:C227–C241. 2002. View Article : Google Scholar : PubMed/NCBI
36	Chandel NS and Schumacker PT: Cellular oxygen sensing by mitochondria: Old questions, new insight. J Appl Physiol (1985). 88:1880–1889. 2000.
37	Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC and Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA. 95:11715–11720. 1998. View Article : Google Scholar : PubMed/NCBI
38	Pearlstein DP, Ali MH, Mungai PT, Hynes KL, Gewertz BL and Schumacker PT: Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol. 22:566–573. 2002. View Article : Google Scholar : PubMed/NCBI
39	Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
40	Boureux A, Vignal E, Faure S and Fort P: Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol. 24:203–216. 2007. View Article : Google Scholar
41	Jaffe AB and Hall A: Rho GTPases: Biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005. View Article : Google Scholar : PubMed/NCBI
42	Bishop AL and Hall A: Rho GTPases and their effector proteins. Biochem J. 48(Pt 2): 241–255. 2000. View Article : Google Scholar
43	Wilkins A and Insall RH: Small GTPases in Dictyostelium: Lessons from a social amoeba. Trends Genet. 17:41–48. 2001. View Article : Google Scholar : PubMed/NCBI
44	Gomez del Pulgar T, Benitah SA, Valerón PF, Espina C and Lacal JC: Rho GTPase expression in tumourigenesis: Evidence for a significant link. Bioessays. 27:602–613. 2005. View Article : Google Scholar : PubMed/NCBI
45	Gouw LG, Reading NS, Jenson SD, Lim MS and Elenitoba-Johnson KS: Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br J Haematol. 129:531–533. 2005. View Article : Google Scholar : PubMed/NCBI
46	Benitah SA, Valerón PF, van Aelst L, Marshall CJ and Lacal JC: Rho GTPases in human cancer: An unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta. 1705:121–132. 2004.PubMed/NCBI
47	Merajver SD and Usmani SZ: Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia. 10:291–298. 2005. View Article : Google Scholar
48	Wong WW, Dimitroulakos J, Minden MD and Penn LZ: HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 16:508–519. 2002. View Article : Google Scholar : PubMed/NCBI
49	Graaf MR, Richel DJ, van Noorden CJ and Guchelaar HJ: Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev. 30:609–641. 2004. View Article : Google Scholar : PubMed/NCBI
50	Denoyelle C, Vasse M, Korner M, Mishal Z, Ganné F, Vannier JP, Soria J and Soria C: Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: An in vitro study. Carcinogenesis. 22:1139–1148. 2001. View Article : Google Scholar : PubMed/NCBI
51	Sawada K, Morishige K, Tahara M, Kawagishi R, Ikebuchi Y, Tasaka K and Murata Y: Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer Res. 62:6015–6020. 2002.PubMed/NCBI
52	Kusama T, Mukai M, Tatsuta M, Nakamura H and Inoue M: Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho. Int J Oncol. 29:217–223. 2006.PubMed/NCBI
53	Bijian K, Takano T, Papillon J, Le Berre L, Michaud JL, Kennedy CR and Cybulsky AV: Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol. 289:F1313–F1323. 2005. View Article : Google Scholar : PubMed/NCBI
54	Gómez J, Martínez C, Giry M, García A and Rebollo A: Rho prevents apoptosis through Bcl-2 expression: Implications for interleukin-2 receptor signal transduction. Eur J Immunol. 27:2793–2799. 1997. View Article : Google Scholar : PubMed/NCBI
55	Blanco-Colio LM, Villa A, Ortego M, Hernández-Presa MA, Pascual A, Plaza JJ and Egido J: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis. 161:17–26. 2002. View Article : Google Scholar : PubMed/NCBI
56	Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P and Marie PJ: RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. 13:1845–1856. 2006. View Article : Google Scholar : PubMed/NCBI
57	Li X, Liu L, Tupper JC, Bannerman DD, Winn RK, Sebti SM, Hamilton AD and Harlan JM: Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem. 277:15309–15316. 2002. View Article : Google Scholar : PubMed/NCBI